Pacritinib and Troleandomycin: Interaction Details

Brand names
Pacritinib
Vonjo
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Troleandomycin

We don't have a drug information page for Troleandomycin because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Troleandomycin? Ask a pharmacist, free →

What Happens When You Take Pacritinib With Troleandomycin

What can happen when they are taken together (rated Contraindicated)

Increased pacritinib exposure and an increased risk of pacritinib-related adverse reactions

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Using pacritinib together with a strong is , since pacritinib exposure may rise substantially and the risk of severe adverse effects may increase. When a single 400 mg dose of pacritinib was given on top of clarithromycin 500 mg twice daily for 5 days (a submaximal dosage of a strong CYP3A4 inhibitor), pacritinib was 1.80-fold higher and was 1.30-fold higher.1

The Pacritinib and Troleandomycin Interaction, Explained

These two medicines should not be taken together. Troleandomycin is an antibiotic that slows down an enzyme in your liver () that helps clear pacritinib, a medicine used for certain bone marrow conditions. When that enzyme is blocked, more pacritinib stays in your body. That can raise the chance of pacritinib side effects such as diarrhea, low blood counts, or bleeding.

In a study with a similar strong blocker (clarithromycin), pacritinib levels rose by about 80%. Please don't stop or change anything on your own. Talk with your pharmacist or doctor, who can review your medicines and choose a safer plan for you.

. Troleandomycin is a strong . Pacritinib is a CYP3A4 , so reduces its and increases exposure (the active drug is pacritinib itself, not a product of this pathway).

  • Magnitude: with clarithromycin 500 mg BID for 5 days, a single 400 mg pacritinib dose showed increased 1.80-fold and 1.30-fold.
  • Risk: increased pacritinib-related adverse reactions (e.g., toxicity, cytopenias, bleeding, QT effects).
  • Onset: unspecified. Evidence: probable.
  • Management: avoid with strong CYP3A4 . Consider a non-interacting alternative antibiotic and review the full medication list.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Pacritinib and Troleandomycin Interact

The likely mechanism

of -mediated of pacritinib

In short: Troleandomycin slows CYP3A4, an enzyme that breaks down pacritinib, so pacritinib can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Pacritinib and Troleandomycin Interaction

The documented management is to avoid using these two medicines together, because troleandomycin can raise pacritinib levels and the chance of side effects.

  • Tell your pharmacist and prescriber about every medicine you take, including antibiotics, before starting anything new.
  • If you have been prescribed both, contact your care team before taking the next dose of either one so they can decide on the best option.
  • Do not stop or change either medicine on your own.

Your care team can often choose a different medicine that does not interact.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Pacritinib or Troleandomycin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: VONJO oral capsules, pacritinib oral capsules

    In a study, when a single 400 mg dose of pacritinib was given together with clarithromycin 500 mg twice daily for 5 days, pacritinib rose 1.80-fold and rose 1.30-fold.1

Pacritinib and Troleandomycin: Common Questions

How serious is the Pacritinib and Troleandomycin interaction?

It is rated . These should generally not be used together.

How is the Pacritinib and Troleandomycin interaction managed?

The documented management is to avoid using these two medicines together, because troleandomycin can raise pacritinib levels and the chance of side effects. Tell your pharmacist and prescriber about every medicine you take, including antibiotics, before starting anything new. If you have been prescribed both, contact your care team before taking the next dose of either one so they can decide on th… Management is individual — always follow your own care team's guidance.

Does taking Pacritinib and Troleandomycin at different times of day help?

No. Taking them at different times of day does not prevent this one. Troleandomycin slows , an enzyme that breaks down pacritinib, so pacritinib can build up in the body. That change lasts while troleandomycin is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Pacritinib and Troleandomycin Interaction

Ask in your own words about taking Pacritinib and Troleandomycin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: VONJO(R) oral capsules, pacritinib oral capsules. CTI BioPharma Corp (per FDA), Seattle, WA, 2024. DailyMed
Was this write-up helpful?

Other Serious Interactions of Pacritinib and Troleandomycin

Also serious with Troleandomycin

Also serious with Pacritinib

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Troleandomycin

With Pacritinib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.